Literature DB >> 34651584

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder-related deficits.

Barbara Terzic1, M Felicia Davatolhagh2, Yugong Ho1, Sheng Tang1, Yu-Ting Liu1, Zijie Xia1, Yue Cui1, Marc V Fuccillo2, Zhaolan Zhou1.   

Abstract

CDKL5 deficiency disorder (CDD) is an early onset, neurodevelopmental syndrome associated with pathogenic variants in the X-linked gene encoding cyclin-dependent kinase-like 5 (CDKL5). CDKL5 has been implicated in neuronal synapse maturation, yet its postdevelopmental necessity and the reversibility of CDD-associated impairments remain unknown. We temporally manipulated endogenous Cdkl5 expression in male mice and found that postdevelopmental loss of CDKL5 disrupts numerous behavioral domains, hippocampal circuit communication, and dendritic spine morphology, demonstrating an indispensable role for CDKL5 in the adult brain. Accordingly, restoration of Cdkl5 after the early stages of brain development using a conditional rescue mouse model ameliorated CDD-related behavioral impairments and aberrant NMDA receptor signaling. These findings highlight the requirement of CDKL5 beyond early development, underscore the potential for disease reversal in CDD, and suggest that a broad therapeutic time window exists for potential treatment of CDD-related deficits.

Entities:  

Keywords:  Development; Genetic diseases; Neurological disorders; Neuroscience; Synapses

Mesh:

Substances:

Year:  2021        PMID: 34651584      PMCID: PMC8516470          DOI: 10.1172/JCI143655

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Critical period regulation.

Authors:  Takao K Hensch
Journal:  Annu Rev Neurosci       Date:  2004       Impact factor: 12.449

Review 2.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

3.  Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications.

Authors:  Przemyslaw Szafranski; Sailaja Golla; Weihong Jin; Ping Fang; Patricia Hixson; Reuben Matalon; Daniel Kinney; Hans-Georg Bock; William Craigen; Janice L Smith; Weimin Bi; Ankita Patel; Sau Wai Cheung; Carlos A Bacino; Paweł Stankiewicz
Journal:  Eur J Hum Genet       Date:  2014-10-15       Impact factor: 4.246

4.  Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice.

Authors:  I-Ting Judy Wang; Megan Allen; Darren Goffin; Xinjian Zhu; Andrew H Fairless; Edward S Brodkin; Steve J Siegel; Eric D Marsh; Julie A Blendy; Zhaolan Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-10       Impact factor: 11.205

5.  Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

Authors:  G Feng; R H Mellor; M Bernstein; C Keller-Peck; Q T Nguyen; M Wallace; J M Nerbonne; J W Lichtman; J R Sanes
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

6.  CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.

Authors:  Scott T Demarest; Heather E Olson; Angela Moss; Elia Pestana-Knight; Xiaoming Zhang; Sumit Parikh; Lindsay C Swanson; Katherine D Riley; Grace A Bazin; Katie Angione; Lisa-Marie Niestroj; Dennis Lal; Elizabeth Juarez-Colunga; Tim A Benke
Journal:  Epilepsia       Date:  2019-07-16       Impact factor: 5.864

Review 7.  Control of microtubule organization and dynamics: two ends in the limelight.

Authors:  Anna Akhmanova; Michel O Steinmetz
Journal:  Nat Rev Mol Cell Biol       Date:  2015-11-12       Impact factor: 94.444

8.  Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1.

Authors:  Grazia Della Sala; Elena Putignano; Gabriele Chelini; Riccardo Melani; Eleonora Calcagno; Gian Michele Ratto; Elena Amendola; Cornelius T Gross; Maurizio Giustetto; Tommaso Pizzorusso
Journal:  Biol Psychiatry       Date:  2015-09-03       Impact factor: 13.382

9.  Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice.

Authors:  Sheng Tang; I-Ting Judy Wang; Cuiyong Yue; Hajime Takano; Barbara Terzic; Katarina Pance; Jun Y Lee; Yue Cui; Douglas A Coulter; Zhaolan Zhou
Journal:  J Neurosci       Date:  2017-07-03       Impact factor: 6.167

10.  Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort.

Authors:  Joseph D Symonds; Sameer M Zuberi; Kirsty Stewart; Ailsa McLellan; Mary O'Regan; Stewart MacLeod; Alice Jollands; Shelagh Joss; Martin Kirkpatrick; Andreas Brunklaus; Daniela T Pilz; Jay Shetty; Liam Dorris; Ishaq Abu-Arafeh; Jamie Andrew; Philip Brink; Mary Callaghan; Jamie Cruden; Louise A Diver; Christine Findlay; Sarah Gardiner; Rosemary Grattan; Bethan Lang; Jane MacDonnell; Jean McKnight; Calum A Morrison; Lesley Nairn; Meghan M Slean; Elma Stephen; Alan Webb; Angela Vincent; Margaret Wilson
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

View more
  6 in total

1.  Flow blockage disrupts cilia-driven fluid transport in the epileptic brain.

Authors:  Regina J Faubel; Veronica S Santos Canellas; Jenna Gaesser; Nancy H Beluk; Tim N Feinstein; Yong Wang; Maya Yankova; Kalyani B Karunakaran; Stephen M King; Madhavi K Ganapathiraju; Cecilia W Lo
Journal:  Acta Neuropathol       Date:  2022-08-18       Impact factor: 15.887

Review 2.  CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.

Authors:  William Hong; Isabel Haviland; Elia Pestana-Knight; Judith L Weisenberg; Scott Demarest; Eric D Marsh; Heather E Olson
Journal:  CNS Drugs       Date:  2022-05-28       Impact factor: 6.497

3.  CDKL5 deficiency disorder: a pathophysiology of neural maintenance.

Authors:  Peter C Kind; Adrian Bird
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

Review 4.  CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.

Authors:  Nicole J Van Bergen; Sean Massey; Anita Quigley; Ben Rollo; Alexander R Harris; Robert M I Kapsa; John Christodoulou
Journal:  Biochem Soc Trans       Date:  2022-08-31       Impact factor: 4.919

5.  Touchscreen cognitive deficits, hyperexcitability and hyperactivity in males and females using two models of Cdkl5 deficiency.

Authors:  Anna Adhikari; Fiona K B Buchanan; Timothy A Fenton; David L Cameron; Julian A N M Halmai; Nycole A Copping; Kyle D Fink; Jill L Silverman
Journal:  Hum Mol Genet       Date:  2022-09-10       Impact factor: 5.121

6.  Active human full-length CDKL5 produced in the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125.

Authors:  Andrea Colarusso; Concetta Lauro; Marzia Calvanese; Ermenegilda Parrilli; Maria Luisa Tutino
Journal:  Microb Cell Fact       Date:  2022-10-14       Impact factor: 6.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.